omeprazole has been researched along with Hypokalemia in 11 studies
Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.
Hypokalemia: Abnormally low potassium concentration in the blood. It may result from potassium loss by renal secretion or by the gastrointestinal route, as by vomiting or diarrhea. It may be manifested clinically by neuromuscular disorders ranging from weakness to paralysis, by electrocardiographic abnormalities (depression of the T wave and elevation of the U wave), by renal disease, and by gastrointestinal disorders. (Dorland, 27th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hypokalemia is a well-described electrolyte disturbance in patients on peritoneal dialysis (PD)." | 1.56 | Hypokalemia and hyperkalemia in patients on peritoneal dialysis: incidence and associated factors. ( Abensur, H; Cordeiro, L; Dalboni, MA; de Araujo, LKRP; de Jesus, JS; Elias, RM; Goncalves, FA; Moysés, RMA; Pereira, BJ; Piraciaba, MCT; Silva, BC; Steller Wagner Martins, C, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (18.18) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 3 (27.27) | 24.3611 |
| 2020's | 3 (27.27) | 2.80 |
| Authors | Studies |
|---|---|
| Goncalves, FA | 1 |
| de Jesus, JS | 1 |
| Cordeiro, L | 1 |
| Piraciaba, MCT | 1 |
| de Araujo, LKRP | 1 |
| Steller Wagner Martins, C | 1 |
| Dalboni, MA | 1 |
| Pereira, BJ | 1 |
| Silva, BC | 1 |
| Moysés, RMA | 1 |
| Abensur, H | 1 |
| Elias, RM | 1 |
| Isse, N | 1 |
| Hashimoto, M | 1 |
| Lattey, K | 1 |
| Quinn, S | 1 |
| O'Brien, K | 1 |
| Hung, AM | 1 |
| Hakim, RM | 1 |
| Jarraya, A | 1 |
| Elleuch, S | 1 |
| Zouari, J | 1 |
| Trigui, K | 1 |
| Sofiene, A | 1 |
| Smaoui, M | 1 |
| Kolsi, K | 1 |
| Shabajee, N | 1 |
| Lamb, EJ | 1 |
| Sturgess, I | 1 |
| Sumathipala, RW | 1 |
| Doornebal, J | 1 |
| Bijlsma, R | 1 |
| Brouwer, RM | 1 |
| Maeda, Y | 1 |
| Kojima, N | 1 |
| Araki, Y | 1 |
| Uno, T | 1 |
| Nishigaki, K | 1 |
| Inaba, N | 1 |
| Aichbichler, BW | 1 |
| Zerr, CH | 1 |
| Santa Ana, CA | 1 |
| Porter, JL | 1 |
| Fordtran, JS | 1 |
| Eiro, M | 1 |
| Katoh, T | 1 |
| Watanabe, T | 1 |
| Faber, J | 1 |
| Azzugnuni, M | 1 |
| Di Romana, S | 1 |
| Vanhaeverbeek, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Development of a Mathematical Model for the Evaluation of the Potassium Kinetic During and After Hemodialysis for the Potassium Profiling in the Dialysate to Prevent Arrhythmias[NCT04563091] | 6 participants (Anticipated) | Interventional | 2018-11-15 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for omeprazole and Hypokalemia
| Article | Year |
|---|---|
Dialysate and serum potassium in hemodialysis.
Topics: Aged; Arrhythmias, Cardiac; Azithromycin; Bicarbonates; Black or African American; Calcium; Coronary | 2015 |
10 other studies available for omeprazole and Hypokalemia
| Article | Year |
|---|---|
Hypokalemia and hyperkalemia in patients on peritoneal dialysis: incidence and associated factors.
Topics: Adult; Aged; Anuria; Female; Humans; Hyperkalemia; Hypokalemia; Incidence; Male; Middle Aged; Omepra | 2020 |
Omeprazole-induced hypomagnesaemia, causing renal tubular acidosis with hypokalaemia, hypocalcaemia, hyperlactacidaemia and hyperammonaemia.
Topics: Acidosis, Renal Tubular; Aged; Humans; Hyperammonemia; Hyperlactatemia; Hypocalcemia; Hypokalemia; M | 2020 |
Over-the-counter antacids linked to severe hypokalaemia in the context of threatened preterm labour.
Topics: Adult; Antacids; Cardiotocography; Drug Overdose; Female; Gastroesophageal Reflux; Humans; Hypokalem | 2021 |
[Hyperemesis gravidarum with severe electrolyte disorders: report of a case].
Topics: Acute Kidney Injury; Antiemetics; Female; Fluid Therapy; Hepatomegaly; Humans; Hyperemesis Gravidaru | 2015 |
Omeprazole and refractory hypomagnesaemia.
Topics: Aged; Aged, 80 and over; Anti-Ulcer Agents; Chronic Disease; Female; Humans; Hypocalcemia; Hypokalem | 2008 |
[An unknown but potentially serious side effect of proton pump inhibitors: hypomagnesaemia].
Topics: Aged; Aged, 80 and over; Anti-Ulcer Agents; Female; Humans; Hypocalcemia; Hypokalemia; Hypoparathyro | 2009 |
Does a proton pump inhibitor cause hypokalemia?
Topics: Aged; Aged, 80 and over; Female; Humans; Hydrogen-Ion Concentration; Hypokalemia; Kidney; Omeprazole | 2011 |
Proton-pump inhibition of gastric chloride secretion in congenital chloridorrhea.
Topics: Adult; Chlorides; Chronic Disease; Diarrhea; Feces; Gastric Mucosa; Humans; Hypokalemia; Intestinal | 1997 |
Use of a proton-pump inhibitor for metabolic disturbances associated with anorexia nervosa.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Alkalosis; Anorexia Nervosa; Bicarbonates; Bulimia; | 2002 |
Fatal confusion between 'Losec' and 'Lasix'.
Topics: Female; Furosemide; Humans; Hypokalemia; Medication Errors; Middle Aged; Omeprazole; Terminology as | 1991 |